HSIC Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03
Prezzo $83.98
Capitalizzazione di Mercato (MRQ) $9.40B
P/E (TTM) 24.5
EPS (TTM) $3.43
Ricavi (TTM) $13.60B
ROE (TTM) 12.2%
D/E Debito/Patrimonio (MRQ) 0.3
Intervallo 52 sett. $62–$92

HSIC Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04
intervallo
barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Split azionari 3
Data ex-dividendo Split Tipo
08 Febbraio 2019 51-for-40 Avanti
15 Settembre 2017 2-for-1 Avanti
01 Marzo 2005 2-for-1 Avanti

Informazioni su Henry Schein, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.

History

In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.

In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.

Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.

In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.

Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.

In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.

In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.

Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.

In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.

In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.

In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.

On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.

In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.

In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.

Operations

Dental

In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.

Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.

Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.

In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.

In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.

In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.

In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.

In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.

In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.

In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.

Henry Schein One

In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.

In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.

In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.

In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.

Medical

In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.

In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.

In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.

In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.

In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).

In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).

Former division

Animal health

Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.

Philanthropy

In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.

Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.

In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.

Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.

In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.

Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.

In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

settoreHealth Care industriaHealth Care dipendenti25.000 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06
Ricavi$13.18B
2016-12-31 → 2025-12-27
EPS$3.27
2016-12-31 → 2025-12-27
Flusso di cassa libero$573M
2016-12-31 → 2025-12-27
Margine netto3.0%
2016-12-31 → 2025-12-27
Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica Tendenza 5 anni HSIC media 5 anni Mediana dei peer Verdetto
P/E (TTM) 24.5media 5 anni ≈21.5 ≈21.5 22.9 Sopravvalutato
P/S (TTM) 0.7media 5 anni ≈0.8 ≈0.8 0.5 Sopravvalutato
P/B (MRQ) 3.0media 5 anni ≈2.8 ≈2.8 · ·
EV / EBITDA 10.6media 5 anni ≈10.4 ≈10.4 · ·
Prezzo / FCF (TTM) 16.5media 5 anni ≈18.5 ≈18.5 · ·
Prezzo / Flusso di cassa (TTM) 13.4media 5 anni ≈14.8 ≈14.8 14.0 Valore equo
EV / Revenue (EV / Ricavi) 0.8media 5 anni ≈0.8 ≈0.8 · ·
EV / FCF 17.8media 5 anni ≈18.9 ≈18.9 · ·
Prezzo / Valore contabile tangibile (MRQ) 4.3 · · ·
PEG Ratio ≈8.1 · · ·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14
Sorpresa media 0.97%
Prossimo report Nov 02, 2026
PeriodoRapportoEPS ActualEPS StimatoSorpresa
30 Giugno 2026 Ago 11, 2026 $1.27 $1.26 0.67%
31 Marzo 2026 Mag 12, 2026 $1.32 $1.24 6.3%
31 Dicembre 2025 $1.34 $1.33 1.1%
30 Settembre 2025 $1.38 $1.30 5.8%
30 Giugno 2025 $1.10 $1.22 -9.5%
31 Marzo 2025 $1.15 $1.13 1.6%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15
Conto Economico 17
Metrica Tendenza 20252024202320222021202020192018201720162015
Revenue $13.18B$12.67B$12.34B$12.65B$12.40B$10.12B$9.99B$9.42B$8.88B$11.57B$10.63B
Cost of Revenue $9.08B$8.66B$8.48B$8.82B$8.73B$7.30B$6.89B$6.51B$6.14B$8.35B$7.62B
Gross Profit $4.11B$4.02B$3.86B$3.83B$3.67B$2.82B$3.09B$2.91B$2.75B$3.23B$3.01B
SG&A Expense $3.08B$3.03B$2.96B$2.77B$2.63B$2.09B$2.36B$2.22B$2.07B$2.41B$2.24B
Operating Expenses ·······$2.70B$2.53B$2.41B·
Operating Income $653M$621M$615M$747M$852M$535M$718M$601M$670M$772M$734M
Interest Expense $150M$131M$87M$35M$27M$41M$51M$76M$51M$32M$26M
Interest Income $33M$24M$17M$8M$6M$10M$16M$15M$12M$13M$13M
Other Non-op $-3M$-1M$-3M$1M$0$-4M$-3M$-3M$-1M$3M$-141.0K
Pretax Income $533M$513M$542M$721M$831M$500M$680M$537M$630M$756M$721M
Income Tax $126M$128M$120M$170M$198M$95M$160M$107M$309M$218M$211M
Net Income $398M$390M$416M$538M$631M$404M$695M$536M$406M$507M$479M
EPS (Basic) $3.29$3.07$3.18$3.95$4.51$2.83$4.70$3.51$2.59$3.14$2.89
EPS (Diluted) $3.27$3.05$3.16$3.91$4.45$2.82$4.65$3.49$2.57$3.10$2.85
Shares (Basic) 120,813,977126,788,997130,618,990136,064,221140,090,889142,504,193147,817,000152,656,000156,787,000161,641,000165,687,000
Shares (Diluted) 121,717,876127,779,228131,748,171137,755,670141,772,781143,403,682149,257,000153,707,000158,208,000163,723,000168,250,000
EBITDA $964M$918M$863M$959M$1.06B$721M$903M$961M·$941M$893M
Stato Patrimoniale 26
Metrica Tendenza 20252024202320222021202020192018201720162015
Cash & Equivalents $156M$122M$171M$117M$118M$421M·$57M$158M$62M$72M
Receivables $1.65B$1.48B$1.86B$1.44B$1.45B$1.42B$1.25B$1.17B$1.52B$1.25B$1.23B
Inventory $2.00B$1.81B$1.81B$1.96B$1.86B$1.51B$1.43B$1.42B$1.93B$1.67B$1.51B
Prepaid Expense $655M$569M$639M$466M$413M$433M$445M$451M$455M$361M$361M
Current Assets $4.46B$3.98B$4.49B$3.99B$3.84B$3.79B$3.23B$4.18B$4.09B$3.34B$3.23B
PP&E (Net) ····$366M$342M$330M$314M$375M$334M$318M
PP&E (Gross) $1.38B$1.20B$1.17B$956M$916M$868M$799M$905M$990M$865M$797M
Accum. Depreciation $759M$670M$672M$573M$550M$526M$469M$591M$615M$531M$478M
Goodwill $4.21B$3.89B$3.88B$2.89B$2.85B$2.50B$2.46B$2.08B$1.55B$2.02B$1.91B
Intangibles $1.02B$1.02B$916M$587M$668M$479M$573M$376M$670M$621M$593M
Total Assets $11.21B$10.22B$10.57B$8.61B$8.48B$7.77B$7.15B$8.50B$7.86B$6.81B$6.53B
Accounts Payable $1.15B$962M$1.02B$1.00B$1.05B$1.01B$880M$786M$1.15B$1.01B$1.01B
Short-term Debt $764M$650M$264M$103M$51M$73M$24M$951M···
Current Liabilities $3.23B$2.80B$2.68B$2.22B$2.31B$2.28B$2.04B$3.22B$2.83B$2.32B$2.15B
Capital Leases $251M$259M$310M$275M$268M$239M$176M$0···
Deferred Tax $146M$102M$54M$36M$42M$30M$65M$27M$50M$52M$253M
Other Non-current Liabilities $486M$387M$436M$361M$377M$393M$331M$358M$420M$264M$212M
Total Liabilities $6.42B$5.38B$5.42B$3.94B$3.81B$3.46B$3.23B$4.65B$4.21B$3.35B$3.08B
Long-term Debt ···$1.05B$822M······
Total Debt $764M$650M$264M$103M$51M$73M$24M····
Paid-in Capital $177M$0$0$0$0$0$48M$0···
Retained Earnings $3.29B$3.77B$3.86B$3.68B$3.60B$3.45B$3.12B$3.21B$2.94B$2.98B$2.90B
AOCI $-226M$-379M$-206M$-233M$-171M$-108M$-167M$-249M$-130M$-317M$-220M
Stockholders' Equity $3.25B$3.39B$3.65B$3.45B$3.42B$3.35B$3.00B$2.96B$2.81B$2.79B$2.88B
Liabilities + Equity $11.21B$10.22B$10.57B$8.61B$8.48B$7.77B$7.15B$8.50B$7.86B$6.76B$6.50B
Shares Outstanding 115,771,149124,155,884129,247,765131,792,817137,145,558142,462,571143,353,459151,401,668153,690,146158,805,010164,830,640
Flusso di cassa 19
Metrica Tendenza 20252024202320222021202020192018201720162015
D&A $311M$297M$248M$212M$210M$186M$185M$144M$134M$170M$159M
Stock-based Comp $39M$39M$39M$54M$78M$9M$45M$33M$37M$58M$45M
Deferred Tax $5M$-61M$-20M$-73M$-11M$-53M$-4M$-25M$1M$-37M$-6M
Amort. of Intangibles $180M$185M$152M$126M$124M$106M$108M$75M$70M$98M$93M
Restructuring $105M$110M$80M$128M$8M··$54M$0$46M$35M
Other Non-cash $-41M$183M$-183M$-129M$-199M$54M$-266M$-54M·$-82M$-90M
Operating Cash Flow $712M$848M$500M$602M$710M$599M$654M$685M$546M$643M$616M
CapEx $139M$148M$147M$96M$79M$49M$76M$71M$62M$70M$72M
Investing Cash Flow $-400M$-430M$-1.14B$-276M$-677M$-115M$-424M$-193M$-342M$-316M$-260M
Debt Issued $489M$120M$1.37B$270M$305M$501M$741.0K$115M$200M$261M$135M
Net Debt Issued $445M$-198M$900M$211M$183M$-110M$-260M$87M·$245M$-66M
Stock Issued $250M$0$0········
Stock Repurchased $850M$385M$250M$485M$401M$74M$525M$200M$450M$550M$300M
Net Stock Activity $-600M$-385M$-250M$-485M$-401M$-74M$-525M$-200M·$-550M$-300M
Financing Cash Flow $-188M$-510M$701M$-315M$-333M$-187M$-216M$-604M$-113M$-327M$-348M
Net Change in Cash $34M$-49M$54M$-1M$-303M$315M$26M$-94M$225M$-10M$-17M
Taxes Paid $128M··········
Free Cash Flow $573M$700M$353M$506M$631M$550M$578M$594M·$545M$515M
Levered FCF $458M$602M$285M$472M$610M$517M$539M$533M·$523M$497M
Redditività 8
Metrica Tendenza 20252024202320222021202020192018201720162015
Gross Margin 31.1%31.7%31.3%30.3%29.6%27.8%30.9%27.2%·28.0%28.3%
Operating Margin 5.0%4.9%5.0%5.9%6.9%5.3%7.2%5.7%·6.7%6.9%
Net Margin 3.0%3.1%3.4%4.2%5.1%4.0%7.0%4.1%·4.4%4.5%
Pretax Margin 4.0%4.0%4.4%5.7%6.7%4.9%6.8%5.3%·6.5%6.8%
EBITDA Margin 7.3%7.2%7.0%7.6%8.6%7.1%9.0%7.3%·8.1%8.4%
ROA 3.7%3.8%4.3%6.3%7.8%5.4%8.9%6.6%·7.6%7.6%
ROE 12.0%11.1%11.7%15.7%18.6%12.7%23.3%18.6%·17.8%16.8%
ROIC 12.4%11.5%12.2%16.1%18.7%12.7%18.2%19.7%·19.7%18.0%
Liquidità e Solvibilità 4
Metrica Tendenza 20252024202320222021202020192018201720162015
Current Ratio 1.41.41.71.81.71.71.61.3·1.41.5
Quick Ratio 0.60.60.80.70.70.60.60.5·0.60.6
Debt / Equity 0.20.20.10.00.00.00.0····
Interest Coverage 4.44.77.117.030.912.914.19.6·24.228.2
Efficienza 3
Metrica Tendenza 20252024202320222021202020192018201720162015
Asset Turnover 1.21.21.31.51.51.41.31.6·1.71.7
Inventory Turnover 4.84.84.54.65.25.04.84.9·5.35.4
Receivables Turnover 8.47.67.58.78.67.68.38.4·9.39.0
Per Azione 5
Metrica Tendenza 20252024202320222021202020192018201720162015
Book Value / Share $28.03$27.33$28.28$26.15$24.97$23.50$20.91$19.56·$35.18$35.00
Revenue / Share $108.32$99.18$93.66$91.81$87.47$70.56$66.90$85.89·$141.36$126.36
Cash Flow / Share $5.85$6.64$3.80$4.37$5.00$4.18$4.38$4.45·$7.52$6.98
Cash / Share $1.35$0.98$1.32$0.89$0.86··$0.53·$0.79$0.87
EPS (TTM) $3.27$3.05$3.16$3.91$4.45$2.82$4.65$3.49·$3.10$2.85
Tassi di Crescita 9
Metrica Tendenza 20252024202320222021202020192018201720162015
Revenue YoY 4.0%2.7%-2.4%2.0%22.6%······
Revenue CAGR 3Y 1.4%0.73%6.8%········
Revenue CAGR 5Y 5.4%··········
EPS YoY 7.2%-3.5%-19.2%-12.1%57.8%······
EPS CAGR 3Y -5.8%-11.8%3.9%········
EPS CAGR 5Y 3.0%··········
Net Income YoY 2.1%-6.2%-22.7%-14.7%56.2%······
Net Income CAGR 3Y -9.6%-14.8%0.98%········
Net Income CAGR 5Y -0.30%··········
Valutazione (TTM) 14
Metrica Tendenza 20252024202320222021202020192018201720162015
Revenue TTM $13.18B$12.67B$12.34B$12.65B$12.40B$10.12B$9.99B$9.42B·$11.57B$10.63B
Net Income TTM $398M$390M$416M$538M$631M$404M$695M$536M·$507M$479M
Market Cap $8.81B$8.74B$9.79B$10.53B$10.28B$9.38B$9.54B$9.25B·$4.72B$5.08B
Enterprise Value $9.42B$9.27B$9.88B$10.51B$10.21B······
P/E 23.323.124.020.416.823.314.317.5·19.221.6
P/S 0.70.70.80.80.80.91.01.0·0.40.5
P/B 2.72.62.73.13.02.83.23.1·1.71.8
P / Tangible Book ·····25.7·····
P / Cash Flow 12.410.319.617.514.515.714.613.5·7.78.7
P / FCF 15.412.527.720.816.317.016.515.6·8.79.9
EV / EBITDA 9.810.111.411.09.6······
EV / FCF 16.413.228.020.816.2······
EV / Revenue 0.70.70.80.80.8······
Earnings Yield 4.3%4.3%4.2%4.9%5.9%4.3%7.0%5.7%·5.2%4.6%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16
Metrica 2025-12-272024-12-282023-12-302022-12-312021-12-25
Ricavi $13.18B $12.67B $12.34B $12.65B $12.40B
Margine Lordo % 31.1% 31.7% 31.3% 30.3% 29.6%
Margine Operativo % 5.0% 4.9% 5.0% 5.9% 6.9%
Utile netto $398M $390M $416M $538M $631M
EPS Diluito $3.27 $3.05 $3.16 $3.91 $4.45

Proprietari istituzionali (13F) 600 filer · $11.2B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 600
Valore detenuto $11.2B
Nuove posizioni 64
Posizioni chiuse 60
Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
64 (-16 vs trimestre precedente) 60 (+14 vs trimestre precedente) 173 (-3 vs trimestre precedente) 220 (+25 vs trimestre precedente) +9.1M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
Kohlberg Kravis Roberts & Co. L.P. $1.307.257.713 15.652.032 11,68% Azioni
VANGUARD GROUP INC $875.836.080 11.588.199 7,82% Azioni
FMR LLC $630.901.802 7.553.901 5,64% Azioni
BlackRock, Inc. $586.699.894 7.024.663 5,24% Azioni
Artisan Partners Limited Partnership $540.162.844 6.467.467 4,82% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $530.073.795 6.346.669 4,73% Azioni
JPMORGAN CHASE & CO $366.432.667 4.342.929 3,27% Azioni
STATE STREET CORP $359.576.652 4.305.276 3,21% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $345.225.076 4.133.442 3,08% Azioni
AMERICAN CENTURY COMPANIES INC $288.743.396 3.457.175 2,58% Azioni
DIMENSIONAL FUND ADVISORS LP $283.495.786 3.394.242 2,53% Azioni
Southpoint Capital Advisors LP $275.616.000 3.300.000 2,46% Azioni
Invesco Ltd. $263.107.794 3.150.237 2,35% Azioni
CITADEL ADVISORS LLC $243.970.523 2.921.103 2,18% Azioni
GEODE CAPITAL MANAGEMENT, LLC $227.537.373 2.729.030 2,03% Azioni
Palestra Capital Management LLC $204.347.632 2.446.691 1,83% Azioni
BANK OF MONTREAL /CAN/ $176.687.394 2.115.510 1,58% Azioni
MORGAN STANLEY $175.460.572 2.100.819 1,57% Azioni
FIDUCIARY MANAGEMENT INC /WI/ $151.785.323 1.817.353 1,36% Azioni
Burgundy Asset Management Ltd. $151.049.204 2.170.871 1,35% Azioni
LYRICAL ASSET MANAGEMENT LP $122.553.156 1.467.351 1,09% Azioni
UBS Group AG $111.653.127 1.336.843 1,00% Azioni
Swedbank AB $109.479.854 1.310.822 0,98% Azioni
M.D. Sass, LLC $107.485.396 1.286.942 0,96% Azioni
SNYDER CAPITAL MANAGEMENT L P $107.341.992 1.285.225 0,96% Azioni
SCHRODER INVESTMENT MANAGEMENT GROUP $107.262.144 1.272.537 0,96% Azioni
NORGES BANK $103.383.729 1.237.832 0,92% Azioni
BANK OF AMERICA CORP /DE/ $101.266.079 1.212.477 0,90% Azioni
GOLDMAN SACHS GROUP INC $98.070.544 1.174.216 0,88% Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $86.593.118 1.036.795 0,77% Azioni
NORTHERN TRUST CORP $80.548.694 964.424 0,72% Azioni
NOMURA HOLDINGS INC $77.065.658 922.721 0,69% Azioni
PZENA INVESTMENT MANAGEMENT LLC $71.888.420 860.733 0,64% Azioni
DME Capital Management, LP $60.013.296 718.550 0,54% Azioni
Ananym Capital Management, LP $57.978.164 694.183 0,52% Azioni
Ulysses Management LLC $55.570.700 665.358 0,50% Azioni
STALEY CAPITAL ADVISERS INC $55.252.489 661.548 0,49% Azioni
VANGUARD FIDUCIARY TRUST CO $45.489.502 544.654 0,41% Azioni
RAYMOND JAMES FINANCIAL INC $42.948.907 514.235 0,38% Azioni
Bank of New York Mellon Corp $42.261.071 505.999 0,38% Azioni
Nuveen, LLC $38.262.099 458.119 0,34% Azioni
DEUTSCHE BANK AG\ $36.574.075 437.908 0,33% Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $35.970.895 430.686 0,32% Azioni
Clarkston Capital Partners, LLC $35.168.100 421.074 0,31% Azioni
LONE PEAK GLOBAL INVESTORS LLC $33.404.158 399.954 0,30% Azioni
GAMCO INVESTORS, INC. ET AL $30.537.668 365.633 0,27% Azioni
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $27.342.332 370.995 0,24% Azioni
PRIVATE MANAGEMENT GROUP INC $27.285.483 326.694 0,24% Azioni
FRANKLIN RESOURCES INC $25.575.244 306.217 0,23% Azioni
BNP PARIBAS FINANCIAL MARKETS $25.194.142 301.654 0,23% Azioni

Mostra tutti i 600 proprietari istituzionali →

Attivisti e proprietari del 5%+ 2 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante Depositato Partecipazione Stato Scopo Deposito
KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 depositi 10 Marzo 2026 16,40% Modifica · SEC
KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 depositi 08 Agosto 2025 13,00% Modifica · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 52 insider · 25 dirigenti · 22 direttori

19
Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Andrea Albertini CEO, Global Dist. & Tech. 08 Settembre 2026 D 116.104 0 0 $0
Thomas C Popeck CEO, Henry Schein Products 19 Marzo 2026 S 86.182 0 1 $-98.630
Frederick M. Lowery CEO 06 Marzo 2026 A 95.156 0 0 $0
Bradford C Connett CEO, NA Distribution Group 19 Marzo 2025 S 62.688 0 0 $0
David B Brous Jr CEO, Strategic Business Group 12 Giugno 2023 S 68.690 0 0 $0
Karen Prange EVP&CEO Gl.AH.Med.Den.Sur.Grp 02 Marzo 2018 A 62.902 0 0 $0
Lonnie Shoff CEO, Global Strat Port Grp 15 Marzo 2016 S 31.000 0 0 $0
Ronald N. South SVP & Chief Financial Officer 16 Marzo 2026 F 88.930 0 0 $0
James P Breslawski President 14 Marzo 2025 D 200.227 0 0 $0
Bridget A Ross President, Global Medical Grp 06 Marzo 2017 A 9.654 0 0 $0
Michael Zack President of Int'l Group 07 Marzo 2013 M 48.716 0 0 $0
Michael S Ettinger EVP & Chief Operating Officer 17 Marzo 2026 G 112.208 0 0 $0
Christine Zayac Sheehy SVP, Chief Human Res. Officer 16 Marzo 2026 F 18.454 0 0 $0
Mark E Mlotek EVP, Chief Strategic Officer 16 Marzo 2026 F 98.372 0 2 $-478.758
Walter Siegel Sr. VP & Chief Legal Officer 14 Marzo 2025 D 43.191 0 0 $0
Lorelei Mcglynn SVP, Chief Human Res. Officer 06 Settembre 2024 S 71.833 0 0 $0
Gerald A Benjamin EVP, Chief Admin. Officer 26 Maggio 2022 S 95.616 0 0 $0
David Mckinley CCO&Pres. Corp. Com. Dev. Grp. 30 Novembre 2018 S 68.012 0 0 $0
Paul Rose SVP, Global Supply Chain 06 Settembre 2017 S 17.841 0 0 $0
Robert Minowitz Pres., Int'l Dental Group EMEA 12 Maggio 2017 S 22.943 0 0 $0
Michael Racioppi SVP Chief Merchandising Offic. 20 Marzo 2017 M 23.088 0 0 $0
Peter M. Mccarthy Pres., Global Animal Health 13 Marzo 2017 S 14.277 0 0 $0
James A. Harding SVP, Chief Technology Officer 08 Marzo 2017 S 16.589 0 0 $0
Stanley Komaroff Senior Advisor 02 Marzo 2016 F 25.144 0 0 $0
Leonard A David SVP, Chief Compliance Officer 17 Marzo 2015 S 12.343 0 0 $0
William K Daniel Direttore 12 Giugno 2026 A 7.641 1 0 $691.900
Scott Philip Serota Direttore 06 Marzo 2026 A 10.790 0 0 $0
Carole T Faig Direttore 06 Marzo 2026 A 8.025 0 0 $0
Anne H. Margulies Direttore 06 Marzo 2026 A 23.153 0 0 $0
Mohamad Ali Direttore 06 Marzo 2026 A 15.075 0 0 $0
Reed Vaughn Tuckson Direttore 06 Marzo 2026 A 12.520 0 0 $0
Robert J. Hombach Direttore 06 Marzo 2026 A 5.421 0 0 $0
Bradley T Sheares Direttore 06 Marzo 2026 A 47.623 0 0 $0
Philip A Laskawy Direttore 06 Marzo 2026 A 24.538 0 1 $-228.544
Carol Raphael Direttore 21 Maggio 2025 F 33.538 0 0 $0
Steven Paladino Direttore 04 Marzo 2024 A 138.272 0 0 $0
Dianne E Rekow Direttore 16 Marzo 2022 A 18.526 0 0 $0
Barry J Alperin Direttore 16 Marzo 2022 A 52.473 0 0 $0
Paul Brons Direttore 03 Marzo 2021 F 16.854 0 0 $0
Shira Goodman Direttore 03 Marzo 2021 A 5.689 0 0 $0
Lawrence S Bacow Direttore 06 Marzo 2018 F 10.115 0 0 $0
Donald J Kabat Direttore 06 Marzo 2018 F 10.874 0 0 $0
Louis W Sullivan Direttore 31 Marzo 2016 A 14.096 0 0 $0
Norman S Matthews Direttore 31 Marzo 2016 A 12.890 0 0 $0
Karyn Mashima Direttore 10 Marzo 2014 F 19.269 0 0 $0
Irving Shafran Direttore 20 Novembre 2003 S 750.000 0 0 $0
Stanley M Bergman · 26 Maggio 2026 G 253.279 0 5 $-7.544.687
Kurt P Kuehn · 10 Marzo 2026 S 15.420 0 1 $-224.562
Deborah Derby · 06 Marzo 2026 A 15.093 0 0 $0
Joseph L Herring · 06 Marzo 2026 A 30.325 0 0 $0
Margaret A Hamburg · 20 Maggio 2009 M 0 0 0 $0
Pamela Joseph · 16 Novembre 2004 S 98.879 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 86 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
RSPH · Invesco Exchange-Traded Fund Trust 1,59% 163.520 SH 02 Ottobre 2026 Giornaliero
GURU · Global X Funds 1,29% 9.179 NS 31 Luglio 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 0,87% 106.077 NS 31 Luglio 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 0,65% 126.921 SH 02 Ottobre 2026 Giornaliero
FBCV · FIDELITY COVINGTON TRUST 0,36% 7.509 NS 31 Luglio 2026 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0,33% 18.150 NS 31 Luglio 2026 N-PORT
IQSM · New York Life Investments ETF Trust 0,33% 12.855 NS 31 Luglio 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 0,28% 54.697 SH 02 Ottobre 2026 Giornaliero
BKMC · BNY Mellon ETF Trust 0,23% 17.140 NS 31 Luglio 2026 N-PORT
DFAT · Dimensional ETF Trust 0,22% 364.767 NS 31 Luglio 2026 N-PORT
RSP · Invesco Exchange-Traded Fund Trust 0,20% 2.218.557 SH 02 Ottobre 2026 Giornaliero
FSMD · FIDELITY COVINGTON TRUST 0,20% 57.583 NS 31 Luglio 2026 N-PORT
DFAS · Dimensional ETF Trust 0,19% 343.006 NS 31 Luglio 2026 N-PORT
ESML · iShares Trust 0,18% 58.607 SH 11 Settembre 2026 Giornaliero
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0,17% 41.019 NS 31 Luglio 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0,17% 1.416.056 SH 19 Agosto 2026 Giornaliero
FNX · First Trust Exchange-Traded AlphaDE… 0,15% 24.666 NS 31 Luglio 2026 N-PORT
FNK · First Trust Exchange-Traded AlphaDE… 0,15% 3.879 NS 31 Luglio 2026 N-PORT
IYH · iShares Trust 0,14% 57.526 SH 11 Settembre 2026 Giornaliero
NUSC · Nushares ETF Trust 0,14% 20.654 NS 31 Luglio 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,12% 46.652 NS 31 Luglio 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,12% 293.098 SH 19 Agosto 2026 Giornaliero
SMMD · iShares Trust 0,12% 52.697 SH 11 Settembre 2026 Giornaliero
IXJ · iShares Trust 0,11% 51.636 SH 11 Settembre 2026 Giornaliero
VB · VANGUARD INDEX FUNDS 0,10% 2.230.411 SH 19 Agosto 2026 Giornaliero
CURE · Direxion Shares ETF Trust 0,10% 1.905 NS 31 Luglio 2026 N-PORT
EQAL · Invesco Exchange-Traded Fund Trust … 0,09% 8.660 SH 02 Ottobre 2026 Giornaliero
VFMF · VANGUARD WELLINGTON FUND 0,09% 7.550 SH 19 Agosto 2026 Giornaliero
IWS · iShares Trust 0,08% 146.411 SH 10 Settembre 2026 Giornaliero
TILT · FlexShares Trust 0,08% 20.224 NS 31 Luglio 2026 N-PORT
WSML · iShares Trust 0,08% 6.020 SH 11 Settembre 2026 Giornaliero
VFVA · VANGUARD WELLINGTON FUND 0,07% 7.214 SH 19 Agosto 2026 Giornaliero
RWL · Invesco Exchange-Traded Fund Trust … 0,07% 77.119 SH 02 Ottobre 2026 Giornaliero
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,07% 6.494 NS 31 Luglio 2026 N-PORT
IWR · iShares Trust 0,06% 403.437 SH 11 Settembre 2026 Giornaliero
DFUV · Dimensional ETF Trust 0,06% 98.929 NS 31 Luglio 2026 N-PORT
DFSU · Dimensional ETF Trust 0,05% 13.423 NS 31 Luglio 2026 N-PORT
XOEF · iShares Trust 0,05% 125 SH 11 Settembre 2026 Giornaliero
DFAC · Dimensional ETF Trust 0,05% 270.764 NS 31 Luglio 2026 N-PORT
DXUV · Dimensional ETF Trust 0,05% 2.999 NS 31 Luglio 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0,04% 5.048 SH 02 Ottobre 2026 Giornaliero
FAB · First Trust Exchange-Traded AlphaDE… 0,04% 858 NS 31 Luglio 2026 N-PORT
CATH · Global X Funds 0,04% 6.000 NS 31 Luglio 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,04% 44.360 SH 02 Ottobre 2026 Giornaliero
DCOR · Dimensional ETF Trust 0,03% 13.104 NS 31 Luglio 2026 N-PORT
VOOV · VANGUARD ADMIRAL FUNDS 0,03% 22.387 SH 19 Agosto 2026 Giornaliero
IVE · iShares Trust 0,03% 160.669 SH 11 Settembre 2026 Giornaliero
IUSV · iShares Trust 0,03% 83.684 SH 11 Settembre 2026 Giornaliero
CHRI · Global X Funds 0,03% 24 NS 31 Luglio 2026 N-PORT
DSI · iShares Trust 0,02% 14.799 SH 10 Settembre 2026 Giornaliero
IWD · iShares Trust 0,02% 218.760 SH 11 Settembre 2026 Giornaliero
VONV · VANGUARD SCOTTSDALE FUNDS 0,02% 59.466 SH 19 Agosto 2026 Giornaliero
EGLE · Global X Funds 0,02% 5 NS 31 Luglio 2026 N-PORT
DFAU · Dimensional ETF Trust 0,02% 25.929 NS 31 Luglio 2026 N-PORT
XYLG · Global X Funds 0,02% 132 NS 31 Luglio 2026 N-PORT
QVML · Invesco Exchange-Traded Fund Trust … 0,02% 3.116 SH 02 Ottobre 2026 Giornaliero
TOPC · iShares Trust 0,02% 59 SH 10 Settembre 2026 Giornaliero
XCLR · Global X Funds 0,01% 6 NS 31 Luglio 2026 N-PORT
XVV · iShares Trust 0,01% 1.104 SH 11 Settembre 2026 Giornaliero
PTLC · Pacer Funds Trust 0,01% 5.070 NS 31 Luglio 2026 N-PORT
IVV · iShares Trust 0,01% 1.220.662 SH 11 Settembre 2026 Giornaliero
XYLD · Global X Funds 0,01% 4.788 NS 31 Luglio 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0,01% 576 SH 02 Ottobre 2026 Giornaliero
DFUS · Dimensional ETF Trust 0,01% 30.222 NS 31 Luglio 2026 N-PORT
IWB · iShares Trust 0,01% 68.043 SH 11 Settembre 2026 Giornaliero
XRMI · Global X Funds 0,01% 70 NS 31 Luglio 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,01% 365 NS 31 Luglio 2026 N-PORT
IWV · iShares Trust 0,01% 27.083 SH 09 Settembre 2026 Giornaliero
IYY · iShares Trust 0,01% 4.036 SH 10 Settembre 2026 Giornaliero
QDPL · Pacer Funds Trust 0,01% 2.304 NS 31 Luglio 2026 N-PORT
ITOT · iShares Trust 0,01% 123.729 SH 11 Settembre 2026 Giornaliero
PHDG · Invesco Actively Managed Exchange-T… 0,01% 77 SH 02 Ottobre 2026 Giornaliero
HCMT · Direxion Shares ETF Trust 0,01% 674 NS 31 Luglio 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0,01% 2.513.394 SH 19 Agosto 2026 Giornaliero
VTI · VANGUARD INDEX FUNDS 0,01% 3.089.160 SH 19 Agosto 2026 Giornaliero
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 81.658 SH 19 Agosto 2026 Giornaliero
VONE · VANGUARD SCOTTSDALE FUNDS 0,01% 16.261 SH 19 Agosto 2026 Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS 0,01% 8.309 SH 19 Agosto 2026 Giornaliero
ESGV · VANGUARD WORLD FUND 0,01% 22.281 SH 19 Agosto 2026 Giornaliero
SPXL · Direxion Shares ETF Trust 0,01% 7.569 NS 31 Luglio 2026 N-PORT
XTR · Global X Funds 0,01% 4 NS 31 Luglio 2026 N-PORT
DFSV · Dimensional ETF Trust 0,00% 99 NS 31 Luglio 2026 N-PORT
ISCB · iShares Trust · 4.208 SH 11 Settembre 2026 Giornaliero
ISCV · iShares Trust · 20.757 SH 11 Settembre 2026 Giornaliero
SMLF · iShares Trust · 8.316 SH 11 Settembre 2026 Giornaliero
SMMV · iShares Trust · 19.508 SH 19 Agosto 2026 Giornaliero

HSIC Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21
rating · 25 analisti COMPRA
Target mediano $100.00 +19,1%
7 28,0% Acquisto forte
8 32,0% Compra
9 36,0% Mantieni
1 4,0% Vendi
0 0,0% Vendita forte

Target Price a 12 Mesi

15 analisti · 2026-09-30

Target medio $97.27 +15,8%

Ora Prezzo attuale $83.98
Basso$64.00 Media$97.27 Alto$110.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
HSIC $8.81B 23.3 4.0% 3.0% 12.0% 31.1%
MCK $242.30B 22.5 12.4% 1.2% -224.3% 3.6%
COR $60.61B 39.3 9.3% 0.48% 144.3% 3.6%
CAH · 32.9 14.2% 0.67% -60.5% 3.8%
AHCO $1.35B -19.2 -0.49% -2.2% -4.6% ·
ACH · · · · · ·
MEDS · · · · · ·

Ultime notizie Notizie recenti che menzionano questa società

23

Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento

25

Nessun segnale aperto al momento — nessuna scheda è compilata, e questo è onesto.

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Fonte: SEC 10-Q depositato Ago 4, 2026